Structure based on 4fv8

Ideal structure
Name: 6-({4-[(3-cyclopropyl-1h-pyrazol-5-yl)amino]-5-(phenylamino)pyrimidin-2-yl}amino)-1,2-dihydro-3h-indazol-3-one
Formula: C23 H21 N9 O
Weight: 439.473
SMILES: "O=C1NNc2cc(Nc3ncc(Nc4ccccc4)c(Nc5[nH]nc(c5)C6CC6)n3)ccc12"
Spacial conformation based on PDB 4fv8
RESIDUE   E63     54
CONECT      O      1 C1  
CONECT      C1     3 O    C3   N1  
CONECT      C3     3 C1   C4   C2  
CONECT      C4     3 C3   C5   H4  
CONECT      C5     3 C4   C6   H5  
CONECT      C6     3 C5   C23  N3  
CONECT      C23    3 C6   C2   H21 
CONECT      C2     3 C3   C23  N2  
CONECT      N2     3 C2   N1   H3  
CONECT      N1     3 C1   N2   H2  
CONECT      N3     3 C6   C7   H6  
CONECT      C7     3 N3   N9   N4  
CONECT      N9     2 C7   C22 
CONECT      C22    3 N9   C15  H20 
CONECT      C15    3 C22  N8   C8  
CONECT      N8     3 C15  C16  H14 
CONECT      C16    3 N8   C21  C17 
CONECT      C21    3 C16  C20  H19 
CONECT      C20    3 C21  C19  H18 
CONECT      C19    3 C20  C18  H17 
CONECT      C18    3 C19  C17  H16 
CONECT      C17    3 C16  C18  H15 
CONECT      C8     3 C15  N4   N5  
CONECT      N4     2 C7   C8  
CONECT      N5     3 C8   C9   H7  
CONECT      C9     3 N5   C11  N6  
CONECT      C11    3 C9   C10  H8  
CONECT      C10    3 C11  N7   C12 
CONECT      N7     2 C10  N6  
CONECT      N6     3 C9   N7   H1  
CONECT      C12    4 C10  C14  C13  H9  
CONECT      C14    4 C12  C13  H12  H13 
CONECT      C13    4 C12  C14  H11  H10 
CONECT      H4     1 C4  
CONECT      H5     1 C5  
CONECT      H21    1 C23 
CONECT      H3     1 N2  
CONECT      H2     1 N1  
CONECT      H6     1 N3  
CONECT      H20    1 C22 
CONECT      H14    1 N8  
CONECT      H19    1 C21 
CONECT      H18    1 C20 
CONECT      H17    1 C19 
CONECT      H16    1 C18 
CONECT      H15    1 C17 
CONECT      H7     1 N5  
CONECT      H8     1 C11 
CONECT      H1     1 N6  
CONECT      H9     1 C12 
CONECT      H12    1 C14 
CONECT      H13    1 C14 
CONECT      H11    1 C13 
CONECT      H10    1 C13 
END   
HET    E63             54
HETNAM     E63 6-({4-[(3-cyclopropyl-1H-pyrazol-5-yl)amino]-5-(phenyla
HETNAM   2 E63 mino)pyrimidin-2-yl}amino)-1,2-dihydro-3H-indazol-3-one
FORMUL      E63    C23 H21 N9 O1

This OCA MONOMER page
uses Jmol, developed by the Jmol Development Team (color reference)
OCA© by Jaime Prilusky, 1996-2004,2006,2010,2014
Bioinformatics Unit
Weizmann Institute of Science